ERBB2 and breast carcinoma: Although, our previous efforts using deep learning have yielded promising results in applications to segmentation of cervical cancer [4], breast cancer [5], ovarian cancer [6,7] and HER2 status evaluation in breast cancer [8], some challenges limit its utility in practice.